As quarterly earnings dominate investor attention, market experts are warning that an obsession with short-term performance may cause investors to overlook future multibaggers in sectors like manufacturing and pharmaceuticals.

With India’s manufacturing cycle gaining strength and pharmaceutical exports and capex on the rise, analysts are flagging companies that are consciously trading near-term profitability for long-term growth. These firms are investing heavily in research, expanding capacity, and making strategic acquisitions that could unlock significant future value. Advertisement

Gurmeet Chadha, Managing Partner and CIO at Complete Circle Consultants, urged investors to look beyond quarterly earnings in a recent post on X. “In manufacturing and pharma, look at companies investing

See Full Page